Daptomycin

NDC 0143-9455 · Hikma Pharmaceuticals USA Inc.

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength350 mg/7mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryNDA

Packages

0143-9455-01 — 1 VIAL, SINGLE-USE in 1 CARTON (0143-9455-01) / 7 mL in 1 VIAL, SINGLE-USE

J0873 — Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg Medicare Part B payment limit (ASP + 6%): $0.04

FDA lists these products with the same active ingredient.

0143-9444 — Daptomycin, 0143-9445 — daptomycin, 0143-9456 — daptomycin, 0143-9465 — Daptomycin, 0338-0712 — Daptomycin in Sodium Chloride, 0338-0714 — Daptomycin in Sodium Chloride, 0338-0716 — Daptomycin in Sodium Chloride, 0338-0718 — Daptomycin in Sodium Chloride, 0409-0120 — DAPTOMYCIN, 0409-0122 — DAPTOMYCIN, 14335-120 — daptomycin, 16729-434 — Daptomycin, 16729-435 — Daptomycin, 25021-174 — daptomycin, 25021-179 — Daptomycin, 31722-215 — Daptomycin, 31722-216 — Daptomycin, 42023-295 — Daptomycin, 43598-413 — Daptomycin, 43598-476 — Daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.